Pianko, S., Zeuzem, S., Chuang, W. L., Foster, G. R., Sarin, S. K., Flisiak, R., . . . Jacobson, I. M. (2018). Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Chicago Style CitationPianko, S., et al. Randomized Trial of Albinterferon Alfa-2b Every 4 Weeks for Chronic Hepatitis C Virus Genotype 2/3. 2018.
MLA CitationPianko, S., et al. Randomized Trial of Albinterferon Alfa-2b Every 4 Weeks for Chronic Hepatitis C Virus Genotype 2/3. 2018.
Warning: These citations may not always be 100% accurate.